Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Get Free Report) COO Michael Manelis sold 7,825 shares of the company's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $64.31, for a total transaction of $503,225.75. Following the sale, the chief operating officer directly owned 44,713 shares of the company's stock, valued at $2,875,493.03. This represents a 14.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Vivmark Residential Common Shares of Beneficial Interest Trading Up 0.6%

NYSE VMRK traded up $0.38 during trading on Wednesday, reaching $64.41. 6,131,899 shares of the company's stock were exchanged, compared to its average volume of 4,406,111. The company has a current ratio of 0.19, a quick ratio of 0.19 and a debt-to-equity ratio of 0.77. Vivmark Residential Common Shares of Beneficial Interest has a fifty-two week low of $57.57 and a fifty-two week high of $71.50. The firm has a market capitalization of $24.15 billion, a PE ratio of 15.77, a PEG ratio of 5.37 and a beta of 0.73.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Evercore started coverage on shares of Vivmark Residential Common Shares of Beneficial Interest in a report on Tuesday. They issued an "in-line" rating and a $72.00 target price on the stock. Stifel Nicolaus lowered their price objective on shares of Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a "buy" rating on the stock in a research note on Wednesday. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $75.25.

Read Our Latest Analysis on Vivmark Residential Common Shares of Beneficial Interest

Trending Headlines about Vivmark Residential Common Shares of Beneficial Interest

Here are the key news stories impacting Vivmark Residential Common Shares of Beneficial Interest this week:

• Positive Sentiment: Stifel Nicolaus maintained a “buy” rating and trimmed its price target only slightly, from $79.00 to $78.50. The target remains well above the recent trading level, signaling continued confidence in Vivmark’s potential. Benzinga article
• Positive Sentiment: Evercore initiated coverage with an “in-line” rating and a $72.00 price target. Although not an outright bullish rating, the target indicates potential appreciation and adds institutional research coverage. Tickerreport article
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast from $4.06 to $4.07, FY2027 EPS from $4.20 to $4.21, and Q1 2027 EPS from $1.00 to $1.02. These increases suggest slightly improved expectations for near- and medium-term profitability.
• Neutral Sentiment: The analyst consensus still projects steady earnings progression, including approximately $4.40 in FY2028 EPS, but the revisions are small and do not represent a major change to Vivmark’s outlook.
• Negative Sentiment: Zacks lowered estimates for Q3 2026, Q2 2027, Q3 2027, Q1 2028, and FY2028. The FY2028 forecast declined from $4.43 to $4.40, indicating modest pressure on longer-term earnings expectations.

Vivmark Residential Common Shares of Beneficial Interest Company Profile

(Get Free Report)

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.

See Also

• Five stocks we like better than Vivmark Residential Common Shares of Beneficial Interest
• Bloom Energy’s AI Surge Meets a Valuation Reality Check
• Target Is Winning Shoppers Back—Can the Rally Reach $180?
• IonQ’s Space Contract Points to a New Frontier for Quantum Investors
• Is Apple’s AI Strategy Smarter Than Skeptics Think?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vivmark Residential Common Shares of Beneficial Interest Right Now?

Before you consider Vivmark Residential Common Shares of Beneficial Interest, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivmark Residential Common Shares of Beneficial Interest wasn't on the list.

While Vivmark Residential Common Shares of Beneficial Interest currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here